Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts.

@article{Lambiase2016EvaluationOS,
  title={Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts.},
  author={Pier Lambiase and Michael R Gold and Margaret Hood and Lucas V. A. Boersma and Dominic A Theuns and M. Christine Burke and Raul Weiss and Andrea M Russo and Stefan K{\"a}{\"a}b and Bradley P Knight},
  journal={Heart rhythm},
  year={2016},
  volume={13 5},
  pages={
          1066-74
        }
}
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a potential alternative to transvenous systems in hypertrophic cardiomyopathy (HCM) where lead complications are a significant issue. OBJECTIVES To compare the S-ICD efficacy of defibrillation threshold (DFT) testing, arrhythmia therapy, and complications in HCM versus non-HCM patients. METHODS Outcomes of patients with HCM implanted with S-ICD were compared to non-HCM S-ICD recipients using pooled data from a… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 9 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

Similar Papers

Loading similar papers…